Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beyond Air, Inc. Director's Dealing 2025

Nov 24, 2025

35161_dirs_2025-11-24_47b6ebbd-1b98-4960-8329-83d29211939f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beyond Air, Inc. (XAIR)
CIK: 0001641631
Period of Report: 2025-11-04

Reporting Person: Gaul Michael A. (Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-04 Stock Options (Right to buy) $10.80 D 17500 Disposed Common Stock (17500) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 17500 Acquired Common Stock (17500) Direct
2025-11-04 Stock Options (Right to buy) $10.80 D 8500 Disposed Common Stock (8500) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 8500 Acquired Common Stock (8500) Direct
2025-11-04 Stock Options (Right to buy) $10.80 D 3500 Disposed Common Stock (3500) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 3500 Acquired Common Stock (3500) Direct
2025-11-04 Stock Options (Right to buy) $10.80 D 1250 Disposed Common Stock (1250) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 1250 Acquired Common Stock (1250) Direct
2025-11-04 Stock Options (Right to buy) $10.80 D 500 Disposed Common Stock (500) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 500 Acquired Common Stock (500) Direct
2025-11-04 Stock Options (Right to buy) $10.80 D 2000 Disposed Common Stock (2000) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 2000 Acquired Common Stock (2000) Direct
2025-11-04 Stock Options (Right to buy) $5.892 D 20000 Disposed Common Stock (20000) Direct
2025-11-04 Stock Options (Right to buy) $1.95 A 20000 Acquired Common Stock (20000) Direct

Footnotes

F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged.

F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.